Immunophenotypic abnormalities of CD8+ T-cell subsets in a patient with unusual Good's Syndrome

Allergologia et Immunopathologia

Volumn 38, Issue 2, 2010, Pages 102-105

  Del Pozo, N ^a   Sarmiento, E ^a   Lanio, N ^a   Gallego, A ^a   Largo, J ^b   Carbone, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BICARBONATE; CARBENOXOLONE; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; COLCHICINE; CORTICOSTEROID; FAMCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; METRONIDAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SALICYLIC ACID; VALGANCICLOVIR; ANTIINFECTIVE AGENT;

ADULT; ANEMIA; CAMPYLOBACTER ENTERITIS; CANCER RADIOTHERAPY; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EFFECTOR CELL; FEMALE; FLUID THERAPY; GOODPASTURE SYNDROME; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPHENOTYPING; INGUINAL HERNIA; LETTER; MEDIASTINUM MASS; MEMORY T LYMPHOCYTE; MOUTH ULCER; MULTIPLE CYCLE TREATMENT; OPPORTUNISTIC INFECTION; PNEUMONIA; POLYMERASE CHAIN REACTION; PROTEUS; RECURRENT DISEASE; RELAPSE; RESPIRATORY TRACT INFECTION; STOMACH BIOPSY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THRUSH; THYMECTOMY; THYMOMA; URINARY TRACT INFECTION; VAGINAL ULCER; VIDEO ASSISTED THORACOSCOPIC SURGERY; AGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PATHOLOGY; SYNDROME; ULCER;

AGAMMAGLOBULINEMIA; ANTI-BACTERIAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CROHN DISEASE; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTE ACTIVATION; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; SYNDROME; THYMOMA; THYMUS NEOPLASMS; ULCER;

EID: 77951109491     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2009.07.002     Document Type: Letter

References (10)

1. Good R.A., MacLean L.D., Varco R.L., Zak S.J. Thymic tumor and acquired agammaglobulinemia: a clinical and experimental study of the immune response. Surgery 1956, 40:1010-1017.
2. Kelleher P., Misbah S.A. What is Good's syndrome? Immunological findings in patients with thymoma. J Clin Pathol 2003, 56:12-16.
3. Raschal S., Siegel J.N., Huml J., Richmond G.W. Hypogammaglobulinemia and anemia 18 years after thymoma resection. J Allergy Clin Immunol 1997, 100:846-848.
4. Tarr P.E., Sneller M.C., Mechanic L.J., Economides A., Eger C.M., Strober W., et al. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) 2001, 80:123-133.
5. Tarr P.E. Granulocyte-macrophage colony-stimulating factor and the immune system. Med Oncol 1996, 13:133-140.
6. Bussolino F., Ziche M., Wang J.M. In vitro and in vivo activation of endothelial cells by colony stimulating factors. J Clin Invest 1991, 87:986-995.
7. Cianfarani F., Tommasi R., Failla C.M., Viviano M.T., Annessi G., Papi M., et al. ranulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol 2006, 154:34-41.
8. Bacanli A., Yerebakan Dicle O., Parmaksizoglu B., Yilmaz E., Alpsoy E. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease. J Eur Acad Dermatol Venereol 2006, 20:931-935.
9. Sarmiento E., Fernandez-Yañez J., Muñoz P., Palomo J., Rodríguez-Molina J.J., Bermejo J., et al. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Int Immunopharmacol 2005, 5:97-101.
10. Lanio N., Sarmiento E., Gallego A., Carbone J. Immunophenotypic profile of T cells in common variable immunodeficiency: is there an association with different clinical findings?. Allergol Immunopathol (Madr) 2009, 37:14-20.